Akèy › Myozit › North Carolina › Durham
Etid klinik pou Myozit nan Durham, NC
10 etid pou Myozit ap chèche patisipan nan sit nan ak bò kote Durham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Environmental Risk Factors for the Anti-synthetase Syndrome
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · 7 mi lwen
Adult and Juvenile Myositis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · 7 mi lwen
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Ap rekriteFaz 2/3
- Duke University Medical Center - Accepting Young Adults and Juvenile Patients, Durham
- University of North Carolina at Chapel Hill - Accepting Adult Patients, Chapel Hill · 10 mi lwen
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Ap rekriteFaz 1
- Research Site, Chapel Hill · 10 mi lwen
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Ap rekriteFaz 1
- Duke University Medical Center, Durham
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Ap rekriteFaz 1
- University of North Carolina TraCS Institute - CTRC, Chapel Hill · 10 mi lwen
Descartes-08 in Autoantibody Myositis
Ap rekriteFaz 2
- University of North Carolina, Chapel Hill · 10 mi lwen
A Study of AZD0120 in Autoimmune Diseases
Ap rekriteFaz 1
- Research Site, Chapel Hill · 10 mi lwen
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Ap rekriteFaz 1
- Duke University, Durham
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Ap rekriteFaz 1
- Duke University Health System, Durham
Etid Myozit nan lòt vil
- New York City, NY6 etid
- Chicago, IL6 etid
- Boston, MA6 etid
- Houston, TX5 etid
- Cedar Rapids, IA4 etid
- Miami, FL4 etid
- Orange, CA3 etid
- Plantation, FL3 etid
- Ann Arbor, MI3 etid
- Gainesville, FL3 etid
- Dallas, TX3 etid
- Charlotte, NC3 etid
Lòt etid nan Durham
- Kansè nan tete63 etid
- Kansè (tout kalite)58 etid
- Kansè Poumon ki pa ti selil39 etid
- Myelom Miltip37 etid
- Kansè Metastatik33 etid
- Leksemi mieloïd egi33 etid
- Kansè poumon32 etid
- Kansè pwostat32 etid
- Kansè kolorektal28 etid
- Lukemi lenfositè kwonik27 etid
- Kansè ovè27 etid
- Ensifizyans kadyak26 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.